XYLO OLIGOSACCHARIDES MARKET ANALYSIS

Regional Analysis

Market Outlook

• Among applications, neutraceuticals & pharmaceuticals segment accounted for the highest market share in the global xylo-oligosaccharides market in 2017. This is due to various advantages of XOS such as water binding capacity, sweetening ability, and fat replacement value. Moreover, xylo-oligosaccharides have a host of health benefits such as it act as an anti-allergic, antioxidant, and anti-inflammatory. Such advantages will attract more pharmaceuticals & neutraceuticals companies to adopt xylo-oligosaccharides as a non-digestible sugar in their products.
• North America held the highest market share in the global xylo-oligosaccharides market in 2017 and is projected to remain the dominant region during the forecast period. This is due to rising health awareness among consumers. According to the U.S. Department of Health & Human Services, 3.9 million adults consumed prebiotic or probiotic products in 2016.
• Asia Pacific is projected to be the fastest growing region in the market over the forecast period, owing to an increasing number of pharmaceutical industries and rising incidence of diabetes in the region. For instance, according to Indian Brand Equity Foundation (IBEF), pharmaceutical industry is the third-largest industry in India in terms of volume and accounted for around 20% of the global pharmaceutical industries in 2017. Asia is home to most diabetic patients in the world. In 2017, according to International Diabetes Federation, the diabetic population of India and China accounted for 8.8% and 10.9% of the total adult’s diabetic population of the respective countries.

Geographies Covered